CPIG
CLYM

Chicago Partners Investment Group’s Climb Bio CLYM Stock Holding History

Chicago Partners Investment Group’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,962
Closed -$55K – 1553
2025
Q4 		$55K Buy
10,962
+630
+6% +$1.51K ﹤0.01% 1277
2025
Q3 		$21.5K Sell
10,332
-2,510
-20% -$4.66K ﹤0.01% 1210
2025
Q2 		$19K Sell
12,842
-2,116
-14% -$2.63K ﹤0.01% 1090
2025
Q1 		$18.1K Sell
14,958
-6,737
-31% -$10.9K ﹤0.01% 925
2024
Q4 		$40.6K Buy
21,695
+4,729
+28% +$17.1K ﹤0.01% 842
2024
Q3 		$80.6K Buy
+16,966
New +$120K ﹤0.01% 786
2024
Q2 		– Sell
-12,104
Closed -$45.4K – 776
2024
Q1 		$45.4K Sell
12,104
-56
-0.5% -$154 ﹤0.01% 724
2023
Q4 		$36.2K Sell
12,160
-646
-5% -$1.68K ﹤0.01% 689
2023
Q3 		$32.8K Sell
12,806
-3,764
-23% -$10.3K ﹤0.01% 646
2023
Q2 		$45.7K Sell
16,570
-1,950
-11% -$5.92K ﹤0.01% 670
2023
Q1 		$52.4K Buy
18,520
+341
+2% +$1.17K ﹤0.01% 649
2022
Q4 		$61.9K Hold
18,179
– – ﹤0.01% 626
2022
Q3 		$55K Sell
18,179
-5,486
-23% -$17.5K ﹤0.01% 577
2022
Q2 		$75K Buy
23,665
+1,456
+7% +$6.89K 0.01% 577
2022
Q1 		$81K Buy
22,209
+9,723
+78% +$90.7K 0.01% 543
2021
Q4 		$100K Buy
+12,486
New +$186K 0.01% 549

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Chicago Partners Investment Group's CLYM Position: Q1 2026 in Review

Chicago Partners Investment Group sold out of Climb Bio (CLYM) in Q1 2026, closing a stake of 10,962 shares — an estimated $55K sold.

Chicago Partners Investment Group first reported a position in CLYM in Q4 2021 and held it in 16 quarters. The position peaked at $100K in Q4 2021. 80 funds tracked by Wall St. Rank hold CLYM as of Q1 2026.

  • Chicago Partners Investment Group reported no remaining Climb Bio position as of Q1 2026 after selling out during the quarter.
  • Chicago Partners Investment Group sold 10,962 Climb Bio shares in Q1 2026, an estimated $55K.
  • Chicago Partners Investment Group first reported a position in Climb Bio in Q4 2021 and held it in 16 quarters.
  • Chicago Partners Investment Group's Climb Bio position peaked at $100K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Climb Bio as of Q1 2026.

Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.